Answers are grounded in this paper and cite their sources.
Novel geometrical architectures of hybrid nanoparticle–protein complexes are generated by chemically synthesizing monodisperse metal nanoparticles in situ in the presence of a stable, stress-related protein. The catalytic activity of the protein–particle hybrids is examined for the reduction of 4-nitrophenol, providing future biofunctional nanoparticle labels for catalytic signal amplification in optical assays.
No takes yet. Share an insight, caveat, or question.
Behrens et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: